PMC:7283670 / 48548-48782 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T289","span":{"begin":18,"end":29},"obj":"Disease"},{"id":"T290","span":{"begin":188,"end":199},"obj":"Disease"},{"id":"T291","span":{"begin":217,"end":225},"obj":"Disease"}],"attributes":[{"id":"A289","pred":"mondo_id","subj":"T289","obj":"http://purl.obolibrary.org/obo/MONDO_0003019"},{"id":"A290","pred":"mondo_id","subj":"T290","obj":"http://purl.obolibrary.org/obo/MONDO_0003019"},{"id":"A291","pred":"mondo_id","subj":"T291","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Therapy:\n1 severe hypokalemia patients;\n3 g/day K+, 34 (SD = 4) g potassium during hospital stay\nGood response of patients to K+ supplements when they inclined to recovery\nInterpretation: hypokalemia is prevailing in COVID‐19 patients"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T487","span":{"begin":52,"end":54},"obj":"http://purl.obolibrary.org/obo/CLO_0001302"}],"text":"Therapy:\n1 severe hypokalemia patients;\n3 g/day K+, 34 (SD = 4) g potassium during hospital stay\nGood response of patients to K+ supplements when they inclined to recovery\nInterpretation: hypokalemia is prevailing in COVID‐19 patients"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T140","span":{"begin":56,"end":58},"obj":"Chemical"},{"id":"T141","span":{"begin":66,"end":75},"obj":"Chemical"}],"attributes":[{"id":"A140","pred":"chebi_id","subj":"T140","obj":"http://purl.obolibrary.org/obo/CHEBI_74807"},{"id":"A141","pred":"chebi_id","subj":"T141","obj":"http://purl.obolibrary.org/obo/CHEBI_26216"}],"text":"Therapy:\n1 severe hypokalemia patients;\n3 g/day K+, 34 (SD = 4) g potassium during hospital stay\nGood response of patients to K+ supplements when they inclined to recovery\nInterpretation: hypokalemia is prevailing in COVID‐19 patients"}

{"project":"LitCovid-sentences","denotations":[{"id":"T535","span":{"begin":9,"end":39},"obj":"Sentence"},{"id":"T536","span":{"begin":40,"end":96},"obj":"Sentence"},{"id":"T537","span":{"begin":97,"end":171},"obj":"Sentence"},{"id":"T538","span":{"begin":172,"end":234},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Therapy:\n1 severe hypokalemia patients;\n3 g/day K+, 34 (SD = 4) g potassium during hospital stay\nGood response of patients to K+ supplements when they inclined to recovery\nInterpretation: hypokalemia is prevailing in COVID‐19 patients"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T183","span":{"begin":18,"end":29},"obj":"Phenotype"},{"id":"T184","span":{"begin":188,"end":199},"obj":"Phenotype"}],"attributes":[{"id":"A183","pred":"hp_id","subj":"T183","obj":"http://purl.obolibrary.org/obo/HP_0002900"},{"id":"A184","pred":"hp_id","subj":"T184","obj":"http://purl.obolibrary.org/obo/HP_0002900"}],"text":"Therapy:\n1 severe hypokalemia patients;\n3 g/day K+, 34 (SD = 4) g potassium during hospital stay\nGood response of patients to K+ supplements when they inclined to recovery\nInterpretation: hypokalemia is prevailing in COVID‐19 patients"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1179","span":{"begin":30,"end":38},"obj":"Species"},{"id":"1180","span":{"begin":114,"end":122},"obj":"Species"},{"id":"1181","span":{"begin":226,"end":234},"obj":"Species"},{"id":"1379","span":{"begin":18,"end":29},"obj":"Disease"},{"id":"1380","span":{"begin":188,"end":199},"obj":"Disease"},{"id":"1381","span":{"begin":217,"end":225},"obj":"Disease"}],"attributes":[{"id":"A1179","pred":"tao:has_database_id","subj":"1179","obj":"Tax:9606"},{"id":"A1180","pred":"tao:has_database_id","subj":"1180","obj":"Tax:9606"},{"id":"A1181","pred":"tao:has_database_id","subj":"1181","obj":"Tax:9606"},{"id":"A1379","pred":"tao:has_database_id","subj":"1379","obj":"MESH:D007008"},{"id":"A1380","pred":"tao:has_database_id","subj":"1380","obj":"MESH:D007008"},{"id":"A1381","pred":"tao:has_database_id","subj":"1381","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Therapy:\n1 severe hypokalemia patients;\n3 g/day K+, 34 (SD = 4) g potassium during hospital stay\nGood response of patients to K+ supplements when they inclined to recovery\nInterpretation: hypokalemia is prevailing in COVID‐19 patients"}